NCT00106834 A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis Status COMPLETED Phase PHASE3
NCT00096655 A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT00076726 A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis Status TERMINATED Phase PHASE2
NCT00074074 Infliximab in Treating Patients With Myelodysplastic Syndrome Status COMPLETED Phase PHASE2
NCT00056264 A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPD Status COMPLETED Phase PHASE3
NCT00051623 A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT00040885 Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) Status COMPLETED Phase PHASE3
NCT00036439 A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT00036387 A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis. Status COMPLETED Phase PHASE3
NCT00036374 A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00033891 Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis Status COMPLETED Phase PHASE2
NCT00029042 Infliximab to Treat Children With Juvenile Rheumatoid Arthritis Status TERMINATED Phase PHASE2